Stockreport

OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer's Trial with Vivo, a Novel genAI Clinical Trial Control Tower [Yahoo! Finance]

INmune Bio Inc. - Common stock  (INMB) 
PDF HOUSTON & BOCA RATON, Fla., December 04, 2024 BUSINESS WIRE OmniScience and INmune Bio NASDAQ: INMB ) today announced a pioneering partnership to revolutionize operatio [Read more]